Search Results 61-70 of 11343 for anti-TNF drugs

  1. Upadacitinib (oral route) - Side effects & dosage - Mayo Clinic

    ... medicines (eg, tumor necrosis factor [TNF] blockers) that did not work well or cannot be tolerated. Upadacitinib is also used to treat moderate to severe ...

  2. Publications - Lynne S. Peterson, M.D. - Mayo Clinic

    ... anti-TNF therapy (poster presentation). European League Against Rheumatism (EULAR).2004;; Peterson LS, Mason T, Mason T, Nelson AM, O'Fallon WM, Gabriel SE ...

  3. Drugs and Supplements that Start with H - Mayo Clinic

    Drugs and Supplements. Search prescription and over-the-counter drugs . ... Adalimumab-fkjp (subcutaneous route). Humalog. Also known as. Insulin lispro ...

  4. Mayo Clinic Q and A: With psoriatic arthritis, the sooner therapy is started, the better

    NSAIDs — If your symptoms are mild, nonsteroidal anti ... Disease-modifying antirheumatic drugs (DMARDs) — These drugs ... TNF-alpha inhibitors block this substance ...

  5. A Study Of The Efficacy And Safety Of Etrolizumab Treatment In Maintenance Of Disease Remission In Ulcerative Colitis Patients Who Are Naive To TNF Inhibitors - Mayo Clinic

    Naive to treatment with any anti-TNF therapy; An inadequate response to or intolerance of prior corticosteroid and/or immunosuppressant treatment; Background ...

  6. Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns and current practices - Mayo Clinic

    Pirfenidone and nintedanib are approved for treatment of idiopathic pulmonary fibrosis (IPF), but questions remain regarding indications and timing of ...

  7. Publications - Ryan W. Stidham, M.D. - Mayo Clinic

    ... anti-TNF agents for the treatment of Crohn's disease. Aliment Pharmacol Ther. 2014 Jun; 39 (12):1349-62 Epub 2014 Apr 20. View PubMed; Waljee AK, Stidham RW ...

  8. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

    ... anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor (TNF) antagonist (adalimumab subcutaneously [SC]), and an immunomodulator (oral ...

  9. Biomarkers of Treatment Response in Rheumatoid Arthritis - Mayo Clinic

    Participation eligibility · TNF inhibitors (adalimumab, certolizumab, etanercept, golimumab, or infliximab) · Abatacept (Orencia; IV or SC) · Tocilizumab (Actemra; ...

  10. Drugs and Supplements that Start with I - Mayo Clinic

    Adalimumab (subcutaneous route). Idacio. Also known as. Adalimumab-aacf (subcutaneous route). Idamycin PFS. Also known as. Idarubicin (intravenous route).